Institution · Lyndra Therapeutics (United States)

Most cited papers from Lyndra Therapeutics (United States)

Lyndra Therapeutics (United States)

What are the most cited papers from Lyndra Therapeutics (United States)?

The most cited paper from Lyndra Therapeutics (United States) is "Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals" (Andrew M. Bellinger et al., 2016), with 269 citations. Next come "Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy" (231) and "Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form" (64).

Published TypeFieldAccess

Showing 24 of 24 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals Andrew M. Bellinger et al. · Science Translational Medicine Open access	16 Nov 2016	269
2	Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy Ameya R. Kirtane et al. · Nature Communications Open access	27 Dec 2017	231
3	Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form David H. Altreuter, Ameya R. Kirtane, Tyler M. Grant et al. · Expert Opinion on Drug Delivery Open access	5 Nov 2018	64
4	Biodistribution of Lipid 5, mRNA, and Its Translated Protein Following Intravenous Administration of mRNA-Encapsulated Lipid Nanoparticles in Rats Lei Ci, Marjie Hard, Hannah Zhang et al. · Drug Metabolism and Disposition Open access	19 May 2023	37
5	A pharmaceutical answer to nonadherence: Once weekly oral memantine for Alzheimer's disease Rosemary L. Kanasty, Susan Low, Nupura Bhise et al. · Journal of Controlled Release Open access	27 Mar 2019	36
6	A multicenter study to evaluate the pharmacokinetics and safety of liposomal bupivacaine for postsurgical analgesia in pediatric patients aged 6 to less than 17 years (PLAY) Christopher F. Tirotta, Alberto J. de Armendi, Nicole D. Horn et al. · Journal of Clinical Anesthesia Open access	14 Sep 2021	34
7	Three-dimensional scaffolds Ying Luo · Elsevier eBooks Book chapter	2020	30
8	Randomized trial of transversus abdominis plane block with liposomal bupivacaine after cesarean delivery with or without intrathecal morphine Ashraf Samir Habib, Srdjan S. Nedeljković, Jean-Louis Horn et al. · Journal of Clinical Anesthesia Open access	7 Oct 2021	28
9	Systemic Exposure, Metabolism, and Elimination of [14C]-Labeled Amino Lipid, Lipid 5, after a Single Administration of mRNA Encapsulating Lipid Nanoparticles to Sprague-Dawley Rats Douglas S. Burdette, Lei Ci, Barclay Shilliday et al. · Drug Metabolism and Disposition Open access	19 May 2023	21
10	Long‐acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study Anders Cervin, Joanne Rimmer, Agnieszka Wróbel et al. · International Forum of Allergy & Rhinology Open access	17 Sep 2021	18
11	Phase 1 clinical study to assess the safety of a novel drug delivery system providing long‐term topical steroid therapy for chronic rhinosinusitis Richard George Douglas, Alkis J. Psaltis, Joanne Rimmer et al. · International Forum of Allergy & Rhinology	15 Jan 2019	17
12	Bone Mineral Density During and After Lactation: A Comparison of African American and Caucasian Women Marilyn Augustine, Robert M. Boudreau, Jane A. Cauley et al. · Calcified Tissue International Open access	28 Aug 2023	9
13	Optimal quantification of residence time distribution profiles from a quality assurance perspective Pooja Bhalode, Sonia M. Razavi, Andrés D. Román-Ospino et al. · International Journal of Pharmaceutics	28 Jan 2023	8
14	Aripiprazole and Dehydro-Aripiprazole Solid Solutions: Crystalline Combinations of Drug and Active Metabolite in Tailored Compositions Jacob T. Trotta, Tarek A. Zeidan, Pranoti A. Tilak et al. · Crystal Growth & Design	May 2020	7
15	Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trial Leslie Citrome, Nayana Nagaraj, Giovanni Traverso et al. · The Lancet Psychiatry	10 Jun 2025	4
16	Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis Randall A. Ow, Steven D. Shotts, Venkata Kakarlapudi et al. · American Journal of Rhinology and Allergy Open access	16 Jun 2022	4
17	Evaluation of LYR‐220 Mometasone Sinonasal Implants in Patients With Chronic Rhinosinusitis and Prior Ethmoid Surgery: Results From the Randomized, Blinded, Controlled BEACON Phase 2 Study Brent Anthony Senior, Randall A. Ow, M. Scott Major et al. · International Forum of Allergy & Rhinology	18 Mar 2025	2
18	Impact of long‐acting implantable LYR‐210 corticosteroid matrices on quality of life of patients with chronic rhinosinusitis in the LANTERN study Joanne Rimmer, Anders Cervin, Agnieszka Wróbel et al. · International Forum of Allergy & Rhinology Open access	8 Feb 2023	2
19	Statistical Data Pre-Treatment for Residence Time Distribution Studies in Pharmaceutical Manufacturing Pooja Bhalode, Sonia M. Razavi, Andrés D. Román-Ospino et al. · SSRN Electronic Journal PreprintOpen access	2022	2
20	A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys Richard W. Foltin, Stephen E. Zale, Kristine A. Sykes et al. · Drug and Alcohol Dependence Open access	6 Aug 2022	2
21	Ultra long‐acting oral therapies for Alzheimer's: Proof of principle Richard E. Scranton, William Avery, Cecilia Kruger et al. · Alzheimer s & Dementia Open access	Dec 2020	2
22	Drug Release and Pharmacokinetic Evaluation of Novel Implantable Mometasone Furoate Matrices in Rabbit Maxillary Sinuses Chang‐Cheng You, Ling-Fang Tseng, Alexander Pappas et al. · American Journal of Rhinology and Allergy	31 Aug 2021	1
23	Safe and Appropriate Use of GLP-1 RAs in Treating Adult Patients With T2D and Macrovascular Disease LaSalle · The Journal of Family Practice Open access	Sep 2022	0
24	P1‐076: A ONCE WEEKLY GASTRORETENTIVE DOSAGE FORM FOR ALZHEIMER'S DISEASE Rosemary L. Kanasty, Susan Low, Nupura Bhise et al. · Alzheimer s & Dementia	Jul 2018	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.